NCI Says Long-Awaited Long Island Breast Cancer Study Now Underway

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 8
Volume 5
Issue 8

BETHESDA, Md--The Long Island Breast Cancer Study Project, ordered by Congress in 1993, is now underway under the auspices of the NCI and the National Institute of Environmental Health Sciences. The study will attempt to determine whether pollutants (pesticides and other chemical irritants) are linked to the area's excessive breast cancer rates.

BETHESDA, Md--The Long Island Breast Cancer Study Project, orderedby Congress in 1993, is now underway under the auspices of theNCI and the National Institute of Environmental Health Sciences.The study will attempt to determine whether pollutants (pesticidesand other chemical irritants) are linked to the area's excessivebreast cancer rates.

During, the 4-year study, being conducted by researchers fromColumbia University School of Public Health, 33 Long Island hospitalswill provide the names of newly diagnosed breast cancer patientswhom the researchers will invite to join the study. Blood andurine samples will be taken prior to treatment, along with a familyand medical history. The researchers will collect dust, water,and soil samples from the homes of 325 participants. Planned enrollmentis 1,600 patients plus 1,600 controls, with results expected by1999.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Multidisciplinary care can help ensure that treatment planning does not deviate from established guidelines for inflammatory breast cancer management.
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight the many advantages to attending the 42nd Annual Miami Breast Cancer Conference, with some additional tidbits to round out the main event.
3 experts in this video
Related Content